Myomo Historical Financial Ratios

MYO Stock  USD 6.21  0.10  1.58%   
Myomo is lately reporting on over 111 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Days Sales Outstanding of 59.9 will help investors to properly organize and evaluate Myomo Inc financial condition quickly.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

About Myomo Financial Ratios Analysis

Myomo IncFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate Myomo investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on Myomo financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across Myomo history.

Myomo Financial Ratios Chart

At this time, Myomo's PTB Ratio is very stable compared to the past year. As of the 11th of December 2024, Days Sales Outstanding is likely to grow to 59.90, while Price To Sales Ratio is likely to drop 7.30.
Add Fundamental
Price To Sales RatioDividend Yield
Ptb RatioDays Sales Outstanding
Book Value Per ShareFree Cash Flow Yield
Invested CapitalOperating Cash Flow Per Share
Average PayablesStock Based Compensation To Revenue
Capex To DepreciationPb Ratio
Ev To SalesFree Cash Flow Per Share
RoicInventory Turnover
Net Income Per ShareDays Of Inventory On Hand
Payables TurnoverSales General And Administrative To Revenue
Average InventoryResearch And Ddevelopement To Revenue
Capex To RevenueCash Per Share
PocfratioInterest Coverage
Payout RatioCapex To Operating Cash Flow
Pfcf RatioDays Payables Outstanding
Net Current Asset ValueIncome Quality
RoeTangible Asset Value
Ev To Operating Cash FlowPe Ratio
Return On Tangible AssetsEv To Free Cash Flow
Earnings YieldIntangibles To Total Assets
Net Debt To E B I T D ACurrent Ratio
Tangible Book Value Per ShareReceivables Turnover
Graham NumberShareholders Equity Per Share
Debt To EquityCapex Per Share
Graham Net NetAverage Receivables
Revenue Per ShareInterest Debt Per Share
Debt To AssetsEnterprise Value Over E B I T D A
Short Term Coverage RatiosPrice Earnings Ratio
Operating CyclePrice Book Value Ratio
Price Earnings To Growth RatioDays Of Payables Outstanding
Dividend Payout RatioPrice To Operating Cash Flows Ratio
Price To Free Cash Flows RatioPretax Profit Margin
Ebt Per EbitOperating Profit Margin
Effective Tax RateCompany Equity Multiplier
Long Term Debt To CapitalizationTotal Debt To Capitalization
Return On Capital EmployedDebt Equity Ratio
Ebit Per RevenueQuick Ratio
Dividend Paid And Capex Coverage RatioNet Income Per E B T
Cash RatioCash Conversion Cycle
Operating Cash Flow Sales RatioDays Of Inventory Outstanding
Days Of Sales OutstandingFree Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage RatiosPrice To Book Ratio
Fixed Asset TurnoverCapital Expenditure Coverage Ratio
Price Cash Flow RatioEnterprise Value Multiple
Debt RatioCash Flow To Debt Ratio
Price Sales RatioReturn On Assets
Asset TurnoverNet Profit Margin
Gross Profit MarginPrice Fair Value
Return On Equity

Price To Sales Ratio

Price to Sales Ratio is figured by comparing Myomo Inc stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on Myomo sales, a figure that is much harder to manipulate than other Myomo Inc multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Average Payables

The average amount owed to suppliers and creditors over a specific period, reflecting the company's payment cycle and credit terms with suppliers.

Inventory Turnover

A ratio showing how many times a company's inventory is sold and replaced over a period, indicating the efficiency of inventory management.

Payout Ratio

Payout Ratio is the proportion of Myomo Inc earnings paid out as dividends to shareholders. Payout Ratio is typically expressed as a percentage but can be shown as dividends paid out as a proportion of cash flow. The payout ratio is used to determine the sustainability of Myomo Inc dividend payments. A lower payout ratio is generally preferable to a higher payout ratio, with a ratio greater than 100% indicating Myomo Inc is paying out more in dividends than it makes in net income.
Most ratios from Myomo's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into Myomo Inc current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
At this time, Myomo's PTB Ratio is very stable compared to the past year. As of the 11th of December 2024, Days Sales Outstanding is likely to grow to 59.90, while Price To Sales Ratio is likely to drop 7.30.
 2021 2022 2023 2024 (projected)
Payables Turnover4.99.315.643.46
Days Of Inventory On Hand83.2596.37108.65130.72

Myomo fundamentals Correlations

-0.96-0.34-0.150.210.27-0.2-0.15-0.961.00.270.370.050.27-0.08-0.170.04-0.21-0.26-1.00.120.24-1.00.150.090.27
-0.960.430.19-0.08-0.250.17-0.011.0-0.96-0.25-0.230.0-0.250.00.1-0.040.040.290.95-0.1-0.250.95-0.05-0.16-0.38
-0.340.430.40.33-0.83-0.650.030.43-0.34-0.83-0.120.26-0.84-0.3-0.56-0.76-0.190.90.360.310.440.360.83-0.06-0.58
-0.150.190.40.11-0.11-0.280.260.19-0.16-0.110.48-0.01-0.220.01-0.22-0.130.140.650.170.170.150.160.26-0.6-0.41
0.21-0.080.330.11-0.2-0.590.11-0.080.21-0.20.210.14-0.23-0.24-0.3-0.260.010.25-0.230.0-0.11-0.230.29-0.420.19
0.27-0.25-0.83-0.11-0.20.68-0.35-0.250.271.00.590.010.99-0.010.590.91-0.05-0.82-0.3-0.44-0.58-0.3-0.75-0.110.3
-0.20.17-0.65-0.28-0.590.68-0.330.17-0.20.680.140.150.69-0.10.710.75-0.12-0.670.18-0.39-0.480.18-0.710.170.16
-0.15-0.010.030.260.11-0.35-0.33-0.01-0.15-0.36-0.5-0.51-0.420.51-0.2-0.180.790.320.170.14-0.040.17-0.14-0.450.5
-0.961.00.430.19-0.08-0.250.17-0.01-0.96-0.25-0.230.0-0.250.00.1-0.040.040.290.95-0.1-0.250.95-0.05-0.16-0.38
1.0-0.96-0.34-0.160.210.27-0.2-0.15-0.960.270.370.050.27-0.09-0.170.04-0.22-0.26-1.00.120.24-1.00.150.10.27
0.27-0.25-0.83-0.11-0.21.00.68-0.36-0.250.270.590.010.99-0.010.590.91-0.05-0.82-0.3-0.44-0.57-0.3-0.75-0.10.3
0.37-0.23-0.120.480.210.590.14-0.5-0.230.370.590.40.54-0.440.160.41-0.38-0.11-0.39-0.21-0.16-0.39-0.01-0.29-0.24
0.050.00.26-0.010.140.010.15-0.510.00.050.010.40.02-0.970.230.0-0.490.08-0.04-0.38-0.03-0.040.260.3-0.2
0.27-0.25-0.84-0.22-0.230.990.69-0.42-0.250.270.990.540.02-0.010.590.89-0.07-0.87-0.3-0.44-0.56-0.3-0.740.010.28
-0.080.0-0.30.01-0.24-0.01-0.10.510.0-0.09-0.01-0.44-0.97-0.01-0.220.00.51-0.090.080.270.030.08-0.28-0.20.14
-0.170.1-0.56-0.22-0.30.590.71-0.20.1-0.170.590.160.230.59-0.220.55-0.12-0.560.16-0.21-0.280.16-0.71-0.080.32
0.04-0.04-0.76-0.13-0.260.910.75-0.18-0.040.040.910.410.00.890.00.550.09-0.77-0.08-0.61-0.8-0.08-0.85-0.160.41
-0.210.04-0.190.140.01-0.05-0.120.790.04-0.22-0.05-0.38-0.49-0.070.51-0.120.09-0.010.23-0.09-0.30.23-0.35-0.180.49
-0.260.290.90.650.25-0.82-0.670.320.29-0.26-0.82-0.110.08-0.87-0.09-0.56-0.77-0.010.290.420.540.290.77-0.25-0.5
-1.00.950.360.17-0.23-0.30.180.170.95-1.0-0.3-0.39-0.04-0.30.080.16-0.080.230.29-0.11-0.21.0-0.12-0.07-0.28
0.12-0.10.310.170.0-0.44-0.390.14-0.10.12-0.44-0.21-0.38-0.440.27-0.21-0.61-0.090.42-0.110.8-0.110.43-0.15-0.2
0.24-0.250.440.15-0.11-0.58-0.48-0.04-0.250.24-0.57-0.16-0.03-0.560.03-0.28-0.8-0.30.54-0.20.8-0.20.710.21-0.46
-1.00.950.360.16-0.23-0.30.180.170.95-1.0-0.3-0.39-0.04-0.30.080.16-0.080.230.291.0-0.11-0.2-0.12-0.07-0.28
0.15-0.050.830.260.29-0.75-0.71-0.14-0.050.15-0.75-0.010.26-0.74-0.28-0.71-0.85-0.350.77-0.120.430.71-0.120.22-0.61
0.09-0.16-0.06-0.6-0.42-0.110.17-0.45-0.160.1-0.1-0.290.30.01-0.2-0.08-0.16-0.18-0.25-0.07-0.150.21-0.070.22-0.23
0.27-0.38-0.58-0.410.190.30.160.5-0.380.270.3-0.24-0.20.280.140.320.410.49-0.5-0.28-0.2-0.46-0.28-0.61-0.23
Click cells to compare fundamentals

Myomo Account Relationship Matchups

Myomo fundamentals Accounts

201920202021202220232024 (projected)
Price To Sales Ratio1.32.962.880.237.687.3
Ptb Ratio2.741.942.590.5716.4417.26
Days Sales Outstanding40.3544.5251.6344.4945.259.9
Book Value Per Share3.293.472.640.90.30.29
Free Cash Flow Yield(2.08)(0.41)(0.25)(2.87)(0.0428)(0.0449)
Operating Cash Flow Per Share(18.67)(2.71)(1.64)(1.45)(0.21)(0.22)
Stock Based Compensation To Revenue0.240.0810.07910.07650.0580.0551
Capex To Depreciation0.550.420.970.210.280.27
Pb Ratio2.741.942.590.5716.4417.26
Ev To Sales0.831.361.81(0.0762)7.366.99
Free Cash Flow Per Share(18.77)(2.73)(1.69)(1.47)(0.21)(0.22)
Roic(2.39)(0.94)(0.66)(1.66)(0.89)(0.93)
Inventory Turnover2.093.684.383.793.362.58
Net Income Per Share(19.2)(3.62)(1.78)(1.52)(0.28)(0.29)
Days Of Inventory On Hand174.8399.2583.2596.37108.65130.72
Payables Turnover2.0414.414.99.315.643.46
Sales General And Administrative To Revenue2.931.711.040.920.830.79
Research And Ddevelopement To Revenue0.560.220.180.160.140.13
Capex To Revenue0.01350.0060330.02360.0071870.0075780.007199
Cash Per Share8.063.682.660.760.30.29
Pocfratio(0.48)(2.48)(4.18)(0.35)(23.94)(25.14)
Interest Coverage(95.0)(22.12)(669.54)(120.28)(138.32)(145.23)
Capex To Operating Cash Flow(0.0132)(0.005027)(0.005065)(0.0342)(0.0236)(0.0248)
Pfcf Ratio(0.48)(2.47)(4.04)(0.35)(23.39)(24.56)
Days Payables Outstanding179.0425.3474.539.2264.6761.43
Income Quality0.970.780.920.950.760.68
Roe(5.83)(1.04)(0.67)(1.69)(0.91)(0.95)
Ev To Operating Cash Flow(0.31)(1.14)(2.63)0.12(22.93)(24.07)
Pe Ratio(0.47)(1.86)(3.85)(0.34)(18.14)(19.05)
Return On Tangible Assets(1.61)(0.82)(0.52)(1.06)(0.56)(0.59)
Ev To Free Cash Flow(0.31)(1.14)(2.54)0.11(22.4)(23.52)
Earnings Yield(2.13)(0.54)(0.26)(2.97)(0.0551)(0.0579)
Net Debt To E B I T D A0.171.071.490.470.780.42
Current Ratio1.585.034.482.562.492.75
Tangible Book Value Per Share3.293.472.640.90.30.29
Receivables Turnover6.399.058.27.078.085.74
Graham Number37.7316.8110.295.551.381.31
Shareholders Equity Per Share3.293.472.640.90.30.29

Pair Trading with Myomo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.

Moving together with Myomo Stock

  0.95GH Guardant HealthPairCorr
  0.79LH LaboratoryPairCorr

Moving against Myomo Stock

  0.77DRIO DarioHealth CorpPairCorr
  0.68EDAP EDAP TMS SAPairCorr
  0.64VERO Venus ConceptPairCorr
  0.32CI Cigna CorpPairCorr
  0.32VTAK Catheter PrecisionPairCorr
The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.
The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Myomo Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myomo. If investors know Myomo will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myomo listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.23)
Revenue Per Share
0.835
Quarterly Revenue Growth
0.813
Return On Assets
(0.31)
Return On Equity
(0.83)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myomo's value and its price as these two are different measures arrived at by different means. Investors typically determine if Myomo is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myomo's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.